Finding May Shed Added Light On, Offer Treatment Hope for Brain-Wasting Diseases
Case Western Reserve University School of Medicine researchers have synthesized the first artificial human prion, a dramatic development in efforts to combat a devastating form of brain disease that has so far eluded treatment and a cure. The new findings are published in Nature Communications.
Prions are proteins that have folded incorrectly. They can bind to neighboring normal proteins in the brain, triggering a domino effect that causes microscopic holes, turning brains into sponge, resulting in progressive deterioration, dementia, and certain death. There are numerous types of prion diseases in humans; the most common being Creutzfeldt-Jakob disease (CJD). Why and how human prion mis-folding occurs has been a mystery that the Case Western Reserve investigative team may have solved with its new findings.
“This accomplishment represents a watershed,” said Jiri G. Safar, MD, professor of pathology and neurology at Case Western Reserve School of Medicine and the study’s lead author. “Until now our understanding of prions in the brain has been limited. Being able to generate synthetic human prions in a test tube as we have done will enable us to achieve a much richer understanding of prion structure and replication. This is crucial for developing inhibitors of their replication and propagation throughout the brain, which is essential for halting prion-based brain disease.”
Researchers already know how to make some forms of laboratory-rodent prions, but until now, none of these was infectious to humans as judged in experiments with humanized mice models. In their new paper, the researchers describe their success in synthesizing a new, highly destructive human prion from a genetically engineered human prion protein expressed in E. coli bacteria. They also discovered an essential cofactor known as Ganglioside GM1—a cell molecule which modulates cell-to-cell signaling—in triggering infectious replication and transmission of prion-based disease. This finding raises the hope for new therapeutic strategies using analog medications with inhibitory or blocking effect on human prion replication.
The CWRU researchers also demonstrated that the replication rate, infectivity, and targeting of specific brain structures by synthetic and naturally occurring prions is determined not by the presence of mis-folded prions per se but by particular variations and modifications in the molecule’s structure—specifically in an area known as the C terminal domain—which control the growth rate of infectious prions. “Our findings explain at the structural level the emergence of new human prions and provide a basis for understanding how seemingly subtle differences in mis-folded protein structure and modifications affect their transmissibility, cellular targeting, and thus manifestation in humans,” said Safar.
Currently, there is no treatment or cure for CJD. Symptoms are similar to those of Alzheimer’s disease, sometimes leading to mis-diagnosis. These include dementia, memory loss, trouble walking, and impaired vision. The occurrence of human prion diseases peaks at ages 60-65, accounting for approximately 1 in 10,000 deaths worldwide. Despite their relative rarity, human prion diseases have gained considerable notoriety and relevance because they display characteristics of neurodegenerative diseases but are infectious. Furthermore, they can spread not only between humans but also from animals to humans by an infectious agent that is highly resistant to inactivation.
Previous prion studies were carried out with laboratory nonhuman prions on mouse and hamster models. While this approach was useful for a general understanding of prion-triggered disease, human prions are different from these strains in both structure and mechanism of replication. Several recent therapeutic trials of human prion diseases have failed. Although these disappointing results may have occurred for multiple reasons, they demonstrate that the results from animal or cellular prion models do not automatically apply to human prions. Creating artificial human prions will allow researchers to engage in an apples-to-apples study process, opening the door to more complete insights into how prions unleash their destructive force, potentially resulting in medications that can stop the disease in its tracks. And since Parkinson’s and Alzheimer’s diseases spread through the brain in similar fashion as CJD, new inroads against these conditions are possible as well.
Safar was lead author of a pioneering paper on a “prion shape detector” published in Nature Medicine in 1998, which received extensive global coverage and has been highly quoted ever since. The current paper in Nature Communications is a continuation of this ground-breaking research.
The Latest on: Artificial human prion
[google_news title=”” keyword=”artificial human prion” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial human prion
- Scientists think they can finally explain why humans don’t have tailson February 29, 2024 at 8:14 am
The researchers compared the genomes of six species of apes, including humans, and 15 species of monkeys with tails to pinpoint key differences between the groups. Once they identified a significant ...
- The Artificial Humanon February 22, 2024 at 3:41 am
Every day, we read something new about Artificial Intelligence - it'll take ... In a new series on BBC Radio 4, Aleks Krotoski (The Digital Human, Radio 4) and Kevin Fong (13 Minutes to the ...
- Does 'zombie deer disease' pose risks for humans?on February 20, 2024 at 9:20 pm
But scientists haven't reached an agreement on whether the condition can spread to humans. Chronic wasting disease is a type of prion disease, according to the Centers for Disease Control and ...
- Possibility of wildlife-to-human crossover heightens concern about chronic wasting diseaseon February 1, 2024 at 4:00 pm
Recent research shows that the barrier to a spillover into humans is less formidable than previously believed and that the prions causing the disease may be evolving to become more able to infect ...
- Alzheimer's May Be Transmissible in Rare Circumstanceson January 28, 2024 at 4:00 pm
Between 1959 and 1985, cadaver-derived human growth hormone was used to treat young patients for pituitary insufficiency. The product was withdrawn after some patients received prion-contaminated ...
- What is a Prion? Fears of Zombie Deer disease epidemic spreading among humans eruptson December 25, 2023 at 7:15 am
The normally healthy brain proteins are triggered to fold abnormally by prion, which is also a type of protein. It has the potential to cause diseases in both humans and animals. These highly ...
- Prion Disease News and Researchon October 9, 2022 at 5:00 pm
In a new study, researchers from the Case Western Reserve University School of Medicine have identified the structure of protein fibrils linked to a hereditary form of human prion disease.
- Protein amplification technology: New advances in human prion disease diagnosison January 9, 2022 at 4:00 pm
Early and accurate diagnosis of human prion diseases is a long-standing difficulty. Currently, the definitive diagnosis of human prion diseases relies on pathognomonic histological features or PrPSc ...
- Samsung’s Artificial Humans Look Eerily, Well, Humanon January 6, 2020 at 1:50 pm
Since mid-December, Samsung has been teasing "artificial humans" through a project called NEON, promising to reveal details at the 2020 Consumer Electronics Show. Well, CES is still a day away ...
via Bing News